Difference between revisions of "C1 inhibitor"
m |
|||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:C1inhibitor.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 08:19, 3 September 2007
| Template:Infobox header| C1 inhibitor | |
|---|---|
| Substrate peptide name | C1 inhibitor |
| Synonyms | C1 esterase inhibitor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P05155 |
| Reactive glutamines | Q453 |
| Reactive lysines | - |
| Substrate sequence | VFEVQQPFLFV |
| Structure | 2OAY |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10799541 |
| Notes | TG2 action does not influence the protein's function |
| Template:Infobox header | | |